(Q38001602)

26 August 2017

Neurofilaments as biomarkers in multiple sclerosis (English)

1 reference

26 August 2017

0 references

0 references

1

Charlotte E Teunissen

1 reference

26 August 2017

Michael Khalil

2

1 reference

26 August 2017

4 April 2012

1 reference

Multiple Sclerosis Journal

26 August 2017

1 reference

26 August 2017

18

1 reference

26 August 2017

552-556

1 reference

26 August 2017

5

1 reference

Natural history of multiple sclerosis: a unifying concept

26 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F1352458512443092

Combination of CSF N-acetylaspartate and neurofilaments in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512443092

EFNS guidelines on disease-specific CSF investigations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512443092

Biological markers in CSF and blood for axonal degeneration in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512443092

Biomarker research in multiple sclerosis: addressing axonal damage and heterogeneity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512443092

Pathogenesis of axonal and neuronal damage in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512443092

Evidence for widespread axonal damage at the earliest clinical stage of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512443092

Neurofilament phosphoforms: surrogate markers for axonal injury, degeneration and loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512443092

A structural scaffolding of intermediate filaments in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512443092

Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512443092

Evidence for acute neurotoxicity after chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512443092

Glial fibrillary acidic protein: a potential biomarker for progression in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512443092

Acute axonal damage predicts clinical outcome in patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512443092

Multiple sclerosis: Neurofilament light chain antibodies are correlated to cerebral atrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512443092

Neurofilament stoichiometry simulations during neurodegeneration suggest a remarkable self-sufficient and stable in vivo protein structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512443092

Elevated neurofilament levels in neurological diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512443092

A method to solubilise protein aggregates for immunoassay quantification which overcomes the neurofilament "hook" effect.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512443092

A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512443092

In vivo detection of myelin proteins in cervical lymph nodes of MS patients using ultrasound-guided fine-needle aspiration cytology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512443092

Increased frequencies of serum antibodies to neurofilament light in patients with primary chronic progressive multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512443092

Patients with progressive multiple sclerosis have elevated antibodies to neurofilament subunit.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512443092

Antigen microarrays identify CNS-produced autoantibodies in RRMS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512443092

The chemokine CXCL13 is a prognostic marker in clinically isolated syndrome (CIS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512443092

Cerebrospinal fluid CXCL13 in multiple sclerosis: a suggestive prognostic marker for the disease course.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512443092

Increased cerebrospinal fluid concentrations of the chemokine CXCL13 in active MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512443092

Prognostic value of cerebrospinal fluid analysis at the time of a first demyelinating event

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512443092

Cerebrospinal fluid chitinase 3-like 1 levels are associated with conversion to multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512443092

Multiple sclerosis-related proteins identified in cerebrospinal fluid by advanced mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512443092

Primary progressive versus relapsing-onset multiple sclerosis: presence and prognostic value of cerebrospinal fluid oligoclonal IgM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512443092

Lipid-specific immunoglobulin M in CSF predicts adverse long-term outcome in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512443092

Intrathecal IgM synthesis predicts the onset of new relapses and a worse disease course in MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512443092

Multiple sclerosis: Identification and clinical evaluation of novel CSF biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512443092

21 January 2018

Identifiers

DOI

10.1177/1352458512443092

1 reference

26 August 2017

1 reference

PubMed ID

22492131